American Century Companies
BBNX

American Century Companies’s Beta Bionics BBNX Stock Holding History

American Century Companies’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
15,360
-8,544
-36% -$102K ﹤0.01% 2742
2026
Q1 		$240K Buy
23,904
+11,880
+99% +$176K ﹤0.01% 2672
2025
Q4 		$366K Buy
+12,024
New +$321K ﹤0.01% 2589

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

American Century Companies's BBNX Position: Q2 2026 in Review

American Century Companies reduced its Beta Bionics (BBNX) stake by 36% in Q2 2026, selling an estimated $102K and leaving 15,360 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

American Century Companies first reported a position in BBNX in Q4 2025 and has held it in 3 quarters since. The position peaked at $366K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • American Century Companies held 15,360 shares of Beta Bionics worth $241K as of Q2 2026.
  • American Century Companies sold 8,544 Beta Bionics shares in Q2 2026, an estimated $102K.
  • Beta Bionics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2742 holding.
  • American Century Companies first reported a position in Beta Bionics in Q4 2025 and has held it in 3 quarters since.
  • American Century Companies's Beta Bionics position peaked at $366K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.